Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
12 studies found for:    HR-11-001
Show Display Options
Rank Status Study
1 Completed An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors
Condition: Malignant Tumors
Intervention: Drug: Gemcitabine HCl Oral Formulation
2 Completed
Has Results
A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: KW-2478;   Drug: Bortezomib
3 Recruiting Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease
Condition: Graft vs Host Disease
Interventions: Drug: Tacrolimus;   Drug: Cyclosporine;   Drug: Methotrexate
4 Recruiting CORAL XT - Open-label Extension Trial of the CORAL Trial
Conditions: Pain;   Neoplasms;   Chronic Pain
Intervention: Drug: Cebranopadol
5 Terminated
Has Results
A Study of Carboplatin + Paclitaxel and MK0683 in Patients With Chemotherapy-naive Non-Small Cell Lung Cancer (NSCLC)(0683-066)
Condition: Neoplasms
Intervention: Drug: MK0683, vorinostat
6 Completed
Has Results
Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets
Condition: Alzheimer Disease
Intervention: Other: No intervention
7 Completed Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: capecitabine;   Drug: oxaliplatin;   Procedure: adjuvant therapy;   Procedure: standard follow-up care
8 Recruiting Efficacy and Safety of Monotherapy With Noradrenaline and Terlipressin in Patients of Cirrhosis With Septic Shock Admitted to Intensive Care Unit
Condition: Cirrhosis With Septic Shock.
Interventions: Drug: Terlipressin;   Drug: Noradrenaline
9 Completed
Has Results
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker
Condition: Type 2 Diabetes
Interventions: Drug: Dapagliflozin;   Drug: Placebo-matching dapagliflozin;   Drug: Oral antidiabetic agent;   Drug: Angiotensin-converting enzyme (ACE) inhibitor or angiotensin-receptor blocker (ARB);   Drug: With or without insulin
10 Unknown  The Acute Effect of a Mobilization With Movement Technique to Improve Internal Rotation of the Shoulder
Conditions: Disorder of Shoulder;   Other Musculoskeletal Disorder;   Contracture
Interventions: Other: Posterior capsule stretching;   Other: Mobilization with movement
11 Completed Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: etoposide phosphate;   Drug: pravastatin sodium
12 Recruiting Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients
Condition: Kidney; Complications, Allograft
Interventions: Drug: Everolimus;   Drug: Tacrolimus;   Drug: Mycophenolic acid

Indicates status has not been verified in more than two years